Webinar

Progress in applying human iPSC-derived cells to drug discovery

In this webinar, four industry experts present data on bit.bio’s deterministically programmed human iPSC-derived ioCells used across key drug discovery stages.
Progress in applying human iPSC-derived cells to drug discovery

Sebastian Fiedler, PhD

Applications Marketing Manager

bit.bio

Progress in applying human iPSC-derived cells to drug discovery

Malika Bsibsi, PhD

Research Leader Neuroscience

Charles River Laboratories

Progress in applying human iPSC-derived cells to drug discovery

Austin Passaro, PhD

Global Product Manager MEA

Axion Biosystems

Progress in applying human iPSC-derived cells to drug discovery
In this webinar, four industry experts present data on bit.bio’s deterministically programmed human iPSC-derived ioCells used across key drug discovery stages.
Progress in applying human iPSC-derived cells to drug discovery

Sebastian Fiedler, PhD

Applications Marketing Manager

bit.bio

Progress in applying human iPSC-derived cells to drug discovery

Malika Bsibsi, PhD

Research Leader Neuroscience

Charles River Laboratories

Progress in applying human iPSC-derived cells to drug discovery

Austin Passaro, PhD

Global Product Manager MEA

Axion Biosystems

In drug discovery, researchers need reliable, ready-to-use human cell models that deliver reproducible results at every stage of the workflow. Join four industry experts as they present data on bit.bio’s deterministically programmed human iPSC-derived ioCells used across key drug discovery stages. Through case studies and real-world applications, you will learn how these cells and the associated protocols support workflows in target identification, assay development, disease modelling, and toxicology.

Key learning points:

  • Discover quick and easy generation of gene knockouts and CRISPR screens for target ID and validation in human iPSC-derived neurons and microglia using CRISPR-Ready ioCells
  • Learn about assay development in neuroinflammation and demyelinating diseases using neuronal and glial co-cultures 
    Explore disease modelling in excitatory neurons with ALS-associated phenotypes using high-throughput MEA
  • See data for predicting drug-induced liver injury in toxicology studies with new human iPSC-derived liver models

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell coding platform behind our cells
Join us Explore the latest roles at bit.bio